Table 1 Baseline patient characteristics at McGill, at Hillel Yaffe and when data was pooled. No statistically significant differences were found between the groups in terms of age, gender distribution, U/S determined nodule size or Bethesda score (p > 0.05 for each category at both centres, 95% CI)
Control | Molecular Testing | |
|---|---|---|
Age (yrs) | 54.1 (48.4–59.8) | 49.2 (46.0–53.5) |
McGill | 52.3 (45.8–58.7) | 48.7 (45.3–52.1) |
Hillel Yaffe | 61.7 (47.2–76.3) | 51.9 (41.2–62.2) |
Female gender (%) | 80.3 | 86.8 |
McGill | 74.9 | 73.6 |
Hillel Yaffe | 85.7 | 100 |
Nodule size (cm) | 1.9 (1.5–2.2) | 1.8 (1.6–2.0) |
McGill | 1.9 (1.6–2.2) | 1.8 (1.6–2.0) |
Hillel Yaffe | 1.4 (0.9–2.5) | 1.6 (1.3–2.2) |
Bethesda Score of VI (%) | 52.8 | 48.8 |
McGill | 44.8 | 45.8 |
Hillel Yaffe | 64.3 | 85.7 |